Assessing potential eye health risk from GLP-1 medications The Potential Risks of GLP-1 Agonists and Semaglutide to Eye Health In recent years, GLP-1 agonists, such as semaglutide (commonly marketed under names like Ozempic and Wegovy), have gained widespread popularity for their ability to help with weight loss and manage type 2 diabetes
David J
When synthetic GLP-1 receptor agonists are administered, they bind to receptors throughout the gastrointestinal system, affecting gut motility, gastric emptying, and intestinal secretion
Case reports document the syndrome occurring within days of co-administration [3]
If you want a broader look at how this antioxidant supports wellness, our guide on Does Glutathione Supplement Work
The SURMOUNT trials showed tirzepatide producing statistically significant improvements in blood pressure, blood sugar control, and triglyceride levels alongside weight loss